Welcome to isctr.org
Update: Consensus Strategies for Device Development for Cardiovascular Disease
Building on our highly successful summit at the 2016 TCT meeting, ISCTR is collaborating with innovators, regulators, industry leaders, and others to create strategies and methodologies designed to achieve the rapid and cost-effective translation of cardiovascular device advances into clinical practice.
Working groups comprised of experts in their field have been formed to focus on specific areas of device development and implementation. The group dedicated to creating an overview of the translational pathway is being chaired by David R. Holmes, Jr., MD, MACC, while separate groups will concentrate on breaking down the methodologies involved in the development of aortic/pulmonic valves, led by Stanton Rowe; mitral/tricuspid valves, headed by Michael Mack, MD, FACC; stents, steered by Charles Simonton, MD, FACC; and catheter ablation devices, led by Douglas Packer, MD. These groups will be developing their sections throughout the summer and we expect to convene a meeting to review their critical efforts in August at the Food and Drug Administration.
Check back often to get more details about this meeting and the development of the documentation of these strategies as they are available. You can learn more about the genesis of this meeting through our coverage of our 2016 TCT summit here.
ESC Congress 2017
ISCTR President Nabil Dib, MD, MSc, FACC
will be presenting “The Optimal Process of Translating Basic Innovations into Clinical Care” during a session on Developments in Cardiovascular Translational Research that will also feature Eugene Braunwald, MD, MACC, MACP, and ISCTR Vice President Anthony DeMaria, MD, MACC.
View presentations from the 9th Annual ISCTR Symposium
Become an ISCTR Member
ISCTR’s member newsletter
International Society for
Cardiovascular Translational Research
The International Society for Cardiovascular Translational Research (ISCTR) is a non-profit organization that was founded in 2007 by Dr Nabil Dib with a goal to expedite scientific discovery to clinical application (patients).